脂联素、内脂素、抵抗素在系统性红斑狼疮患者血清中的变化及临床意义
Changes and clinical significance of serum adipokines in systemic lupus erythematosus

DOI: 10.6040/j.issn.1671-7554.0.2016.1634

Keywords: 系统性红斑狼疮,狼疮肾炎,骨坏死,内脂素,抵抗素,脂联素,
Systemic lupus erythematosus,Lupus nephritis,Visfatin,Resistin,Bone necrosis,Adiponectin

Full-Text   Cite this paper   Add to My Lib

Abstract:

References

[1]	Schiller M, Lorenz HM. Pathogenesis of systemic lupus erythematosus[J]. Immunology Today, 2014, 35(8): 503-511.
[2]	刘伦飞, 王建有, 劳力民, 等. SLE患者胰岛素抵抗和血清抵抗素水平研究[J]. 中华皮肤科杂志, 2009, 42(9): 593-595. LIU Lun Fei, WANG Jianyou, LAO Limin, et al. Insulin resistance and serum resistin levels in patients with systemic lupus erythematosus[J]. Chinese Journal of Dermatology, 2009, 42(9): 593-595.
[3]	Hutcheson J, Ye Y, Han J, et al. Resistin as a potential marker of renal disease in lupus nephritis[J]. Clin Exp Immunol, 2015, 179(3): 435-443.
[4]	Brochu-Gaudreau K, Rehfeldt C, Blouin R, et al. Adiponectin action from head to toe[J]. Endocrine, 2010, 37(1): 11-32.
[5]	Lartigue A, Colliou N, Calbo S, et al. Critical role of TLR2 and TLR4 in autoantibody production and glomerulonephritis in lpr mutation-induced mouse lupus[J]. J Immunol, 2009, 183(10): 6207-6216.
[6]	Elshishtawy H, Ibrahim ED, Helmi A, et al. Resistin in systemic lupus erythematosus: Relation to lupus nephritis and premature atherosclerosis[J]. Egyptian Rheumat, 2012, 34(4): 137-146.
[7]	Moschen AR, Kaser A, Enrich B, et al. Visfatin, an adipocytokine with proinflammatory and immunomodulating properties[J]. J Immunol, 2007, 178(3): 1748-1758.
[8]	Ozgen M, Koca SS, Aksoy K, et al. Visfatin levels and intima-media thicknesses in rheumatic diseases[J]. Clin Rheumatol, 2011, 30(6): 757-763.
[9]	Fouda N, Abaza N, El-Hilaly R, et al. Evaluation of visfatin in patients with systemic lupus erythematosus: Correlation with disease activity and lupus nephritis[J]. World Pumps, 2012, 34(1): 9-17.
[10]	Baker JF, Morales M, Qatanani M, et al. Resistin levels in lupus and associations with disease-specific measures, insulin resistance, and coronary calcification[J]. J Rheumatol, 2011, 38(11): 2369-2375.
[11]	Neumeier M, Weigert J, Sch？ffler A, et al. Different effects of adiponectin isoforms in human monocytic cells[J]. J Leukoc Biol, 2006, 79(4): 803-808.
[12]	Rovin BH, Song H, Hebert LA, et al. Plasma, urine, and renal expression of adiponectin in human systemic lupus erythematosus[J]. Kidney Int, 2005, 68(4): 1825-1833.
[13]	Berner HS, Lyngstadaas SP, Spahr A, et al. Adiponectin and its receptors are expressed in bone-forming cells[J]. Bone, 2004, 35(4): 842-849.
[14]	Shuai B, Shen L, Yang YP, et al. Low plasma adiponectin as a potential biomarker for osteonecrosis of the femoral head[J]. J Rheumatol, 2010, 37(10): 2151-2155.
[15]	Almehed K, DElia HF, Bokarewa M, et al. Role of resistin as a marker of inflammation in systemic lupus erythematosus[J]. Arthritis Res Ther, 2008, 10(1): 15.
[16]	Hutcheson J, Ye Y, Han J, et al. Resistin as a potential marker of renal disease in lupus nephritis[J]. Clin Exp Immunol, 2015, 179(3): 435-443.
[17]	Park HK, Qatanani M, Briggs ER, et al. Inflammatory induction of human resistin causes insulin resistance in endotoxemic mice[J]. Diabetes, 2011, 60(3): 775-783.
[18]	Eilertsen G？, Becker-Merok A, Nossent JC. The influence of the 1997 updated classification criteria for systemic lupus erythematosus: epidemiology, disease presentation, and patient management[J]. J Rheumatol, 2009, 36(3): 552-559.
[19]	Jia SH, Li Y, Parodo J, et al. Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis[J]. J Clin Invest, 2004, 113(9): 1318-1327.
[20]	Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity[J]. Nat Rev Immunol, 2006, 6(10): 772-783.
[21]	Rho YH, Solus J, Sokka T, et al. Adipocytokines Are Associated with Radiographic Joint Damage in Rheumatoid Arthritis[J]. Arthritis Rheumato, 2009, 60(7): 1906-1914.
[22]	Syrbe U, Callhoff J, Conrad K, et al. Adipokine serum levels in patients with ankylosing spondylitis and their relation to clinical parameters and radiographic spinal progression[J]. Arthritis Rheumato, 2015, 67(3): 678-685.
[23]	Evereklioglu C, Inal？z HS, Kirtak N, et al. Serum leptin concentration is increased in patients with Beh？ets syndrome and is correlated with disease activity[J]. Br J Dermatol, 2002, 147(2): 331-336.
[24]	Bilir BE, Güldiken S, Tun？bilek N, et al. The effects of fat distribution and some adipokines on insulin resistance[J]. Endokrynol Pol, 2016, 67(3): 277-282.
[25]	Lago F, Dieguez C, Gómez-Reino J, et al. The emerging role of adipokines as mediators of inflammation and immune responses[J]. Cytokine Growth Factor Rev, 2007, 18(3-4): 313-325.
[26]	Wolf AM, Dominik W, Holger R, et al. Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes[J]. Biochem Biophys Res Commun, 2004, 323: 630-635.
[27]	Bokarewa M, Nagaev I, Dahlberg L, et al. Resistin, an adipokine with potent proinflammatory properties[J]. J Immunol, 2005, 174(9): 5789-5795.
[28]	Tarkowski A, Bjersing J, Shestakov A, et al. Resistin competes with lipopolysaccharide for binding to toll-like receptor 4[J]. J Cell Mol Med, 2010, 14(6B): 1419-1431.

Full-Text